
Shift your focus from tech giants to downstream AI infrastructure providers, specifically targeting fiber optics, optoelectronics (AAOI), and energy/utilities that power data centers. While hardware leaders like Nvidia and Micron remain in a high-volatility "buy the dip" phase, the most favorable risk-adjusted growth is now found in the Biotech sector. Investors should gain exposure to AI-driven drug discovery by allocating 70% to XBI and 30% to ARKG to mitigate the high risk of individual stock failures. In the crypto market, maintain a bearish stance or stay in cash as Bitcoin (BTC) risks a further drop toward the $49,000–$53,000 range. A strategic relative value trade involves buying Robinhood (HOOD) while shorting the broader crypto complex to capitalize on diversified financial revenue during a digital asset downturn.
The discussion focused on the current state of the "AI trade," noting that the initial phase—driven by massive capital expenditure (CapEx) from tech giants—is showing signs of saturation or "cracks."
The analysts identified Biotech as a primary beneficiary of the "third leg" of the AI trade, where AI begins to affect the real economy through drug discovery and biology.
The sentiment on the crypto market is currently bearish in the short term, with analysts suggesting that AI has stolen the "volatility" and "attention" from Bitcoin.

By Blockworks
1000x is a crypto markets podcast hosted by professional traders Avi Felman and Jonah Van Bourg. We bring on experts to dive deep into the macro and micro factors that represent the lifeblood of digital money and web3. As an increasing share of economic activity and attention migrates online, tokenomics and price action is increasingly relevant to everyone. If you’re interested in the future of markets and crypto, this show is for you.